Search Within

Andrew D Seidman

  1. "Behavioral Sciences Service"
Formats
  1. Journal Article (24)
  2. Meeting Abstract (13)
  3. Conference Paper (3)
Groups
  1. Behavioral Sciences Service (40)
  2. Breast Medicine Service (40)
  3. Department of Medicine (40)
  4. Psychiatry and Behavioral Sciences, Department of (40)
  5. Solid Tumor Oncology Division (40)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (38)

More Groups

People
  1. Clifford Hudis (38)
  2. Larry Norton (38)
  3. Teresa Gilewski (38)
  4. Violante Currie (24)
  5. Nancy Sklarin (22)
  6. Mary Ellen Moynahan (18)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2017 (1)
  4. 2014 (1)
  5. 2013 (1)
  6. 2011 (2)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Breast Cancer Research and Treatment (7)
  3. Clinical Cancer Research (4)
  4. Cancer Research (3)
  5. Seminars in Oncology (3)
  6. Clinical Breast Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Springer (9)
  3. American Association for Cancer Research (8)
  4. Elsevier Inc. (6)
  5. Oxford University Press (2)
  6. Informa Healthcare (1)

More Publishers

Results (40)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Dickler, M. N.; Rugo, H. S.; Eberle, C.; Brogi, E.; Caravelli, J.; Panageas, K. S.; Boyd, J.; Yeh, B.; Lake, D. E.; Dang, C.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Mature cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; George, R.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
    Journal Article

    Seidman, A. D.; Fornier, M. N.; Esteva, F. J.; Tan, L.; Kaptain, S.; Bach, A.; Panageas, K. S.; Arroyo, C.; Valero, V.; Currie, V.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma
    Journal Article

    Fornier, M. N.; Seidman, A. D.; Theodoulou, M.; Moynahan, M. E.; Currie, V.; Moasser, M.; Sklarin, N.; Gilewski, T.; D'Andrea, G.; Salvaggio, R.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • An immunotherapeutic approach to treatment of breast cancer: Focus on trastuzumab plus paclitaxel
    Journal Article

    Gilewski, T.; Seidman, A.; Norton, L.; Hudis, C.
    Cancer Chemotherapy and Pharmacology (2000)

    Fulltext@MSK | Save
  • Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer
    Journal Article

    D'Andrea, G.; Fennelly, D.; Norton, L.; Baselga, J.; Gilewski, T.; Hudis, C.; Moynahan, M. E.; Raptis, G.; Sklarin, N.; Surbone, A.; more...
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • 5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study
    Journal Article

    Hudis, C.; Fornier, M.; Riccio, L.; Lebwohl, D.; Crown, J.; Gilewski, T.; Surbone, A.; Currie, V.; Seidman, A.; Reichman, B.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save